Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

Ho-Young Yhim, MD PhD, Na Ri Lee, MD PhD, Eun-Kee Song, MD PhD, Chang-Yeol Yim, MD PhD, So Yeon Jeon, MD, Bohee Lee, MD, Jeong-A Kim, MD PhD, Hee Sun Kim, Eun Hae Cho, Jae-Yong Kwak, MD PhD

Blood (2014) 124 (21): 4553.

https://doi.org/10.1182/blood.V124.21.4553.4553

Published: 2014

Journal Articles

The Comparative Analysis of Serum Proteomes for the Discovery of Biomarkers for Essential Thrombocythemia.

Jae-Yong Kwak, MD, PhD, Na-Ri Lee, MD, Eun-Kee Song, MD, Chang-Yeol Yim, MD, PhD, Yong-Geun Kwak, MD, PhD

Blood (2005) 106 (11): 4004.

https://doi.org/10.1182/blood.V106.11.4004.4004

Published: 2005

Journal Articles

The Proteomic Analysis of Sera for the Discovery of Biomarkers for Multiple Myeloma.

Jae-Yong Kwak, MD, Na-Ri Lee, MD, Eun-Gi Song, MD, Chang-Yeol Yim, MD, Yong-Geun Kwak, MD, PhD

Blood (2004) 104 (11): 4870.

https://doi.org/10.1182/blood.V104.11.4870.4870

Published: 2004

Journal Articles

The Change of Vascular Endothelial Growth Factor and Microvessel Density Following Imatinib Mesylate Therapy and Allogeneic Bone Marrow Transplantation in Chronic Myeolid Leukemia.

Jae-Yong Kwak, MD, Na-Ri Lee, MD, Eun-Gi Song, MD, Chang-Yeol Yim, MD, Myoung-Ja Chung, MD, Yong-Gon Jo, MD, Sam-Im Choi, MD

Blood (2004) 104 (11): 4669.

https://doi.org/10.1182/blood.V104.11.4669.4669

Published: 2004

Journal Articles

The Comparative Analysis of Serum Proteomes for the Discovery of Biomarkers for Acute Myeloid Leukemia.

Jae-Yong Kwak, MD, Na-Ri Lee, MD, So-Ri Kim, MD, Chang-Yeol Yim, MD, Eun-Gi Song, MD, Yong-Geun Kwak, MD, PhD

Blood (2004) 104 (11): 4412.

https://doi.org/10.1182/blood.V104.11.4412.4412

Published: 2004

NARROW

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

The Comparative Analysis of Serum Proteomes for the Discovery of Biomarkers for Essential Thrombocythemia.

The Proteomic Analysis of Sera for the Discovery of Biomarkers for Multiple Myeloma.

The Change of Vascular Endothelial Growth Factor and Microvessel Density Following Imatinib Mesylate Therapy and Allogeneic Bone Marrow Transplantation in Chronic Myeolid Leukemia.

The Comparative Analysis of Serum Proteomes for the Discovery of Biomarkers for Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Long-Term Follow-up Results after Imatinib Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease

The Comparative Analysis of Serum Proteomes for the Discovery of Biomarkers for Essential Thrombocythemia.

The Proteomic Analysis of Sera for the Discovery of Biomarkers for Multiple Myeloma.

The Change of Vascular Endothelial Growth Factor and Microvessel Density Following Imatinib Mesylate Therapy and Allogeneic Bone Marrow Transplantation in Chronic Myeolid Leukemia.

The Comparative Analysis of Serum Proteomes for the Discovery of Biomarkers for Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only